- Home
- NSA vs VERA Comparison
NSA vs VERA Comparison
Compare NSA & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSA | VERA |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | 1458 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSA | VERA |
|---|---|---|
| Price | $43.40 | $35.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $34.38 | ★ $81.30 |
| AVG Volume (30 Days) | 1.3M | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.39 | $472.48 |
| P/E Ratio | $56.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.43 | $19.07 |
| 52 Week High | $46.47 | $56.05 |
Technical Indicators
Market Signals| Indicator | NSA | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 37.42 |
| Support Level | $41.07 | $32.48 |
| Resistance Level | $43.89 | $42.05 |
| Average True Range (ATR) | 1.02 | 2.36 |
| MACD | -0.24 | -0.89 |
| Stochastic Oscillator | 11.73 | 5.86 |
Price Performance
Historical ComparisonAbout NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.